Ribometrix, an early stage biotechnology startup that is discovering and developing small molecule drugs to treat human diseases, has rasied $7.8 million in additional funding to advance its RNA-targeting drug discovery platform. The new capital infusion came from existing investors, the Dementia Discovery […]